Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

RxSight (RXST) Other Non Operating Income (2023)

RxSight filings provide 1 years of Other Non Operating Income readings, the most recent being -$1.4 million for Q3 2023.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$1.4 million in Q3 2023 year-over-year; TTM through Sep 2024 was -$1.4 million, a 20.46% increase, with the full-year FY2023 number at -$1.8 million, changed N/A from a year prior.
  • Other Non Operating Income hit -$1.4 million in Q3 2023 for RxSight, down from -$362000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of -$362000.0 in Q2 2023 to a low of -$1.4 million in Q3 2023.